The choice effect on open label placebo for chronic pai

Not Applicable

• Conditions: Chronic Pain; Alternative and Complementary Medicine - Other alternative and complementary medicine; Anaesthesiology - Pain management

• Registration Number: ACTRN12623000144617
• Lead Sponsor: The University of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-02-13
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 205

Inclusion Criteria

• Age 18 and above
• Self-reported persistent pain on more days than not for at least three months
• Self-reported current pain intensity of moderate or greater severity (evidenced by a score of > 3 (/10) on a pain intensity numeric rating scale, PI-NRS).
• Willingness to provide written informed consent
• Willingness to participate and comply with the study protocol
• Fluent in English
• Competent to give consent

Exclusion Criteria

• Current serious illness that requires therapy, where pain is not the primary symptom
• Serious psychiatric illness (e.g., bipolar disorder, schizophrenia)
• Drug or alcohol addiction
• Currently pregnant

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain intensity assessed by Brief Pain inventory[Baseline, 2 weeks post-initiating treatment]